These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 18006160)
21. Dephosphorylation of the linker regions of Smad1 and Smad2/3 by small C-terminal domain phosphatases has distinct outcomes for bone morphogenetic protein and transforming growth factor-beta pathways. Sapkota G; Knockaert M; Alarcón C; Montalvo E; Brivanlou AH; Massagué J J Biol Chem; 2006 Dec; 281(52):40412-9. PubMed ID: 17085434 [TBL] [Abstract][Full Text] [Related]
22. Mutations in bone morphogenetic protein type II receptor cause dysregulation of Id gene expression in pulmonary artery smooth muscle cells: implications for familial pulmonary arterial hypertension. Yang J; Davies RJ; Southwood M; Long L; Yang X; Sobolewski A; Upton PD; Trembath RC; Morrell NW Circ Res; 2008 May; 102(10):1212-21. PubMed ID: 18436795 [TBL] [Abstract][Full Text] [Related]
23. Focal adhesion kinase activity is required for bone morphogenetic protein--Smad1 signaling and osteoblastic differentiation in murine MC3T3-E1 cells. Tamura Y; Takeuchi Y; Suzawa M; Fukumoto S; Kato M; Miyazono K; Fujita T J Bone Miner Res; 2001 Oct; 16(10):1772-9. PubMed ID: 11585340 [TBL] [Abstract][Full Text] [Related]
24. Cooperative assembly of Co-Smad4 MH1 with R-Smad1/3 MH1 on DNA: a molecular dynamics simulation study. Wang G; Li C; Wang Y; Chen G PLoS One; 2013; 8(1):e53841. PubMed ID: 23326519 [TBL] [Abstract][Full Text] [Related]
25. Role of smad- and wnt-dependent pathways in embryonic cardiac development. Pal R; Khanna A Stem Cells Dev; 2006 Feb; 15(1):29-39. PubMed ID: 16522160 [TBL] [Abstract][Full Text] [Related]
26. Modeling and analysis of MH1 domain of Smads and their interaction with promoter DNA sequence motif. Makkar P; Metpally RP; Sangadala S; Reddy BV J Mol Graph Model; 2009 Apr; 27(7):803-12. PubMed ID: 19157940 [TBL] [Abstract][Full Text] [Related]
27. Bone morphogenetic protein activities are enhanced by 3',5'-cyclic adenosine monophosphate through suppression of Smad6 expression in osteoprogenitor cells. Sugama R; Koike T; Imai Y; Nomura-Furuwatari C; Takaoka K Bone; 2006 Feb; 38(2):206-14. PubMed ID: 16203197 [TBL] [Abstract][Full Text] [Related]
28. BMP/SMAD1 signaling sets a threshold for the left/right pathway in lateral plate mesoderm and limits availability of SMAD4. Furtado MB; Solloway MJ; Jones VJ; Costa MW; Biben C; Wolstein O; Preis JI; Sparrow DB; Saga Y; Dunwoodie SL; Robertson EJ; Tam PP; Harvey RP Genes Dev; 2008 Nov; 22(21):3037-49. PubMed ID: 18981480 [TBL] [Abstract][Full Text] [Related]
29. Localization of Smads, the TGF-beta family intracellular signaling components during endochondral ossification. Sakou T; Onishi T; Yamamoto T; Nagamine T; Sampath Tk; Ten Dijke P J Bone Miner Res; 1999 Jul; 14(7):1145-52. PubMed ID: 10404014 [TBL] [Abstract][Full Text] [Related]
30. Smad1/5 and Smad4 expression are important for osteoclast differentiation. Tasca A; Stemig M; Broege A; Huang B; Davydova J; Zwijsen A; Umans L; Jensen ED; Gopalakrishnan R; Mansky KC J Cell Biochem; 2015 Jul; 116(7):1350-60. PubMed ID: 25711193 [TBL] [Abstract][Full Text] [Related]
31. Smad1 interacts with homeobox DNA-binding proteins in bone morphogenetic protein signaling. Shi X; Yang X; Chen D; Chang Z; Cao X J Biol Chem; 1999 May; 274(19):13711-7. PubMed ID: 10224145 [TBL] [Abstract][Full Text] [Related]
32. An extended bipartite nuclear localization signal in Smad4 is required for its nuclear import and transcriptional activity. Xiao Z; Latek R; Lodish HF Oncogene; 2003 Feb; 22(7):1057-69. PubMed ID: 12592392 [TBL] [Abstract][Full Text] [Related]
33. Transforming growth factor beta signaling through Smad1 in human breast cancer cells. Liu X; Yue J; Frey RS; Zhu Q; Mulder KM Cancer Res; 1998 Oct; 58(20):4752-7. PubMed ID: 9788633 [TBL] [Abstract][Full Text] [Related]
34. Smad9 is a new type of transcriptional regulator in bone morphogenetic protein signaling. Tsukamoto S; Mizuta T; Fujimoto M; Ohte S; Osawa K; Miyamoto A; Yoneyama K; Murata E; Machiya A; Jimi E; Kokabu S; Katagiri T Sci Rep; 2014 Dec; 4():7596. PubMed ID: 25534700 [TBL] [Abstract][Full Text] [Related]
35. Glypican-3 modulates inhibitory Bmp2-Smad signaling to control renal development in vivo. Hartwig S; Hu MC; Cella C; Piscione T; Filmus J; Rosenblum ND Mech Dev; 2005 Jul; 122(7-8):928-38. PubMed ID: 15925496 [TBL] [Abstract][Full Text] [Related]
36. Activation of the bone morphogenetic protein signaling pathway induces inhibin beta(B)-subunit mRNA and secreted inhibin B levels in cultured human granulosa-luteal cells. Jaatinen R; Bondestam J; Raivio T; Hildén K; Dunkel L; Groome N; Ritvos O J Clin Endocrinol Metab; 2002 Mar; 87(3):1254-61. PubMed ID: 11889196 [TBL] [Abstract][Full Text] [Related]
37. Traf2 interacts with Smad4 and regulates BMP signaling pathway in MC3T3-E1 osteoblasts. Shimada K; Ikeda K; Ito K Biochem Biophys Res Commun; 2009 Dec; 390(3):775-9. PubMed ID: 19836350 [TBL] [Abstract][Full Text] [Related]
38. A peptide that blocks the interaction of NF-κB p65 subunit with Smad4 enhances BMP2-induced osteogenesis. Urata M; Kokabu S; Matsubara T; Sugiyama G; Nakatomi C; Takeuchi H; Hirata-Tsuchiya S; Aoki K; Tamura Y; Moriyama Y; Ayukawa Y; Matsuda M; Zhang M; Koyano K; Kitamura C; Jimi E J Cell Physiol; 2018 Sep; 233(9):7356-7366. PubMed ID: 29663368 [TBL] [Abstract][Full Text] [Related]